Article | 4/1/2018
US budget impact of increased payer adoption of the Flexitouch advanced pneumatic compression device in lymphedema patients with advanced chronic venous insufficiency and multiple infections
Taylor & Francis Online
Adam Cohen, Engagement Manager, Health Advances; Julia A. Gaebler, Partner, Health Advances; Jessica Izhakoff, Consultant, Health Advances; Laura Gullett, Senior Analyst, Health Advances; Timothy Niecko, MS, Niecko Health Economics, LLC and Thomas O’Donnell, MD, Tactile Medical
To assess the budget impact to a US commercial health plan of providing access to the Flexitouch (FLX) advanced pneumatic compression device (Tactile Medical) to lymphedema (LE) patients with either comorbid chronic venous insufficiency (CVI) or frequent infections.